SCHEMBL27503589

SCHEMBL27503589

COc1cc2ccccc2cc1CC(=O)O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.63
ALDH1A1 P00352 3/20 0.57
KDM4E B2RXH2 2/20 0.57
HPGD P15428 1/20 0.57
DRD2 P14416 1/20 0.52
DRD4 P21917 1/20 0.52
SLC2A1 P11166 1/20 0.51
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
TDP1 Q9NUW8 2/20 0.47
CYP3A4 P08684 1/20 0.47
CAMK2A Q9UQM7 1/20 0.46
GAA P10253 3/20 0.46
PTGS1 P23219 1/20 0.46
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
POLB P06746 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27834259 0.83 SLC2A1 (0.56) ALDH1A1KDM4EHPGDDRD2DRD4
SCHEMBL11420544 0.83 HSD17B10 (0.67) HSD17B10ALDH1A1KDM4ETDP1CYP3A4
SCHEMBL29131708 0.81 TDP1 (0.61) HSD17B10ALDH1A1KDM4EHPGDMEN1
SCHEMBL27917034 0.80 CYP3A4 (0.71) HSD17B10ALDH1A1KDM4EMEN1KMT2A
SCHEMBL9477688 0.80 SLC2A1 (0.54) ALDH1A1KDM4EHPGDDRD2DRD4
SCHEMBL28611348 0.80 HSD17B10 (0.62) HSD17B10ALDH1A1KDM4ETDP1CYP3A4
SCHEMBL27378135 0.79 TDP1 (0.56) HSD17B10ALDH1A1KDM4EHPGDTDP1
SCHEMBL30975093 0.78 PDE4A (0.64) ALDH1A1KDM4EHPGDDRD2DRD4
SCHEMBL155982 0.78 HSD17B10 (0.61) HSD17B10MEN1KMT2ATSHRPOLB
SCHEMBL30975091 0.78 PDE4A (0.64) ALDH1A1KDM4EHPGDDRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1256326-C Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 2006-05-17 CN disclosed
CN-1202152-A Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 1998-12-16 CN disclosed